ArticleNeuroradiology2025
Endovascular treatment of intracranial aneurysms with the Woven EndoBridge- safety and efficacy.
Article in Neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe Woven EndoBridge is a device for endovascular embolization of intracranial aneurysms. The aim of this study is to re-evaluate this treatment method regarding its safety and efficacy and to compare it with the results of alternative treatment strategies (clipping, coiling, etc.) and their outcome known from the literature.
methodsForty-four intracranial aneurysms treated with the Woven EndoBridge were retrospectively identified in a clinic for diagnostic and interventional neuroradiology. The average aneurysm height was 7.1 mm, and the average width was 5.8 mm. Further the average neck diameter (3.6 mm) and the average dome-to-neck ratio (1.6) were determined. Both ruptured and non-ruptured aneurysms were included in this study. Occlusion was assessed using the WEB Occlusion Scale immediately after the intervention and after three, six and twelve months follow-up.
resultsIn 11% of cases (n = 5), implantation of the Woven EndoBridge failed technically. In two patients, a thromboembolic event occurred during the intervention without consequential damage. During the observation period of twelve months, none of the study participants died because of the intervention. After twelve months, 95% of the treated aneurysms (n = 20) showed adequate occlusion.
conclusionCompared to other treatment strategies (clipping, coiling etc.) and their complication rates known from other studies, our results suggest that the Woven EndoBridge is a safe treatment option. Regarding the angiographic results, the Woven EndoBridge achieves occlusion rates which are comparable with those of intravascular flow diverters, but without the need of dual anti-platelet-aggregation therapy.
Indexed as
Identifiers
40498334What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.